Free Trial

Diploma (LON:DPLM) Reaches New 52-Week High - Here's Why

Diploma logo with Industrials background

Shares of Diploma PLC (LON:DPLM - Get Free Report) hit a new 52-week high during trading on Thursday . The stock traded as high as GBX 5,583.91 ($74.98) and last traded at GBX 5,275 ($70.83), with a volume of 2784206 shares changing hands. The stock had previously closed at GBX 4,904 ($65.85).

Wall Street Analyst Weigh In

A number of research firms have issued reports on DPLM. Shore Capital restated a "hold" rating and set a GBX 5,100 ($68.48) price target on shares of Diploma in a report on Thursday. Berenberg Bank increased their target price on Diploma from GBX 5,600 ($75.20) to GBX 5,750 ($77.21) and gave the stock a "buy" rating in a report on Friday.

Read Our Latest Analysis on DPLM

Diploma Trading Down 0.4%

The stock has a market cap of £6.94 billion, a P/E ratio of 59.77, a P/E/G ratio of 2.82 and a beta of 0.75. The company has a debt-to-equity ratio of 62.17, a quick ratio of 0.80 and a current ratio of 2.17. The stock has a 50-day moving average price of GBX 4,712.35 and a 200-day moving average price of GBX 4,363.24.

Diploma (LON:DPLM - Get Free Report) last issued its quarterly earnings results on Wednesday, May 21st. The company reported GBX 80.20 ($1.08) earnings per share (EPS) for the quarter. Diploma had a return on equity of 13.18% and a net margin of 9.25%. On average, equities research analysts expect that Diploma PLC will post 163.7995512 EPS for the current year.

Insiders Place Their Bets

In related news, insider Katie Bickerstaffe purchased 44 shares of the firm's stock in a transaction on Wednesday, May 21st. The shares were acquired at an average cost of GBX 4,867 ($65.36) per share, with a total value of £2,141.48 ($2,875.63). In the last ninety days, insiders purchased 96 shares of company stock valued at $473,173. Insiders own 0.52% of the company's stock.

About Diploma

(Get Free Report)

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.

See Also

Should You Invest $1,000 in Diploma Right Now?

Before you consider Diploma, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diploma wasn't on the list.

While Diploma currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It
NVDA Greenlight: China Sales Spark 50% Rally Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines